巨细胞动脉炎患者报告结局量表的验证
本研究为横断面研究,纳入428例英国临床医生确诊的巨细胞动脉炎患者,通过Rasch分析和探索性因子分析对40个候选条目进行简化,最终形成30条目、四领域的GCA-PRO量表,并验证其结构效度、聚合效度、内部一致性和重测信度均良好。
要点
- 最终GCA-PRO为30条目、四领域量表,包括急性症状、日常生活活动、心理和参与。
- 量表整体Rasch模型拟合良好(χ2=25.219,自由度=24,P=0.394)。
- 与EQ-5D-5L、ICECAP-A和CAT-PROM5的聚合效度经假设检验确认,内部一致性和重测信度极好。
核心结论
- 最终GCA-PRO为30条目、四领域量表,在测量巨细胞动脉炎患者健康相关生活质量方面具有稳健的效度和信度证据。
研究设计与样本
- 横断面研究,纳入428例英国临床医生确诊的巨细胞动脉炎患者,平均(标准差)年龄74.2(7.2)岁,女性285例(67%)。
- 患者在第1次和第2次(间隔3天)完成40个GCA-PRO候选条目、EQ-5D-5L、ICECAP-A、CAT-PROM5及疾病活动自报,采用Rasch分析和探索性因子分析指导条目简化并建立结构效度、信度和单维性。
主要发现
- 研究人群包括颅型GCA 327例(76%)、大血管血管炎114例(26.6%)、眼部受累142例(33.2%)。
- Rasch分析剔除10个候选条目,并将反应类别重构为四点Likert量表;因子分析确认四个领域:急性症状(8条目)、日常生活活动(7条目)、心理(7条目)和参与(8条目)。
- 整体量表Rasch模型拟合良好(χ2=25.219,自由度=24,P=0.394)。
- 与EQ-5D-5L、ICECAP-A和CAT-PROM5的聚合效度经假设检验确认,内部一致性和重测信度极好。
关键数值与推荐
- 最终GCA-PRO为30条目、四领域量表:急性症状8条目、日常生活活动7条目、心理7条目、参与8条目。
- 整体量表Rasch模型拟合:χ2=25.219,自由度=24,P=0.394。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: GCA is systemic vasculitis manifesting as cranial, ocular or large vessel vasculitis. A prior qualitative study developed 40 candidate items to assess the impact of GCA on health-related quality of life (HRQoL). This study aimed to determine final scale structure and measurement properties of the GCA patient reported outcome (GCA-PRO) measure. METHODS: Cross-sectional study included UK patients with clinician-confirmed GCA. They completed 40 candidate items for the GCA-PRO at times 1 and 2 (3 days apart), EQ-5D-5L, ICECAP-A, CAT-PROM5 and self-report of disease activity. Rasch and exploratory factor analyses informed item reduction and established structural validity, reliability and unidimensionality of the final GCA-PRO. Evidence of validity was also established with hypothesis testing (GCA-PRO vs other PRO scores, and between participants with 'active disease' vs those 'in remission') and test-retest reliability. RESULTS: The study population consisted of 428 patients: mean (s.d.) age 74.2 (7.2), 285 (67%) female; 327 (76%) cranial GCA, 114 (26.6%) large vessel vasculitis and 142 (33.2%) ocular involvement. Rasch analysis eliminated 10 candidate GCA items and informed restructuring of response categories into four-point Likert scales. Factor analysis confirmed four domains: acute symptoms (eight items), activities of daily living (seven items), psychological (seven items) and participation (eight items). The overall scale had adequate Rasch model fit (χ2 = 25.219, degrees of freedom = 24, P = 0.394). Convergent validity with EQ5D-5L, ICECAP-A and Cat-PROM5 was confirmed through hypothesis testing. Internal consistency and test-retest reliability were excellent. CONCLUSION: The final GCA-PRO is a 30-item, four-domain scale with robust evidence of validity and reliability in measuring HRQoL in people with GCA.
引用
- Ndosi M, Almeida C, Dawson J, et al. Validation of a patient-reported outcome measure for giant cell arteritis. Rheumatology (Oxford). 2024. PMID: 37144946. doi:10.1093/rheumatology/kead201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。